Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,882 | 36,951 | 29,594 | -16,817 | -26,422 |
| Depreciation Amortization | 13,681 | 9,524 | 7,074 | 5,996 | 3,624 |
| Income taxes - deferred | -28,025 | -23,732 | 0 | N/A | N/A |
| Accounts receivable | -9,250 | -16,442 | 8,578 | -2,581 | -10,089 |
| Other Working Capital | -18,839 | 429 | 8,718 | -18,671 | -3,534 |
| Other Operating Activity | 56,792 | 15,469 | -4,413 | 11,951 | 16,003 |
| Operating Cash Flow | $-7,523 | $22,199 | $49,551 | $-20,122 | $-20,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,711 | -4,242 | -1,103 | -111 | -324 |
| Net Acquisitions | -11,785 | -86,467 | -12,996 | N/A | N/A |
| Purchase Of Investment | -13,212 | -87,171 | -275,198 | -252,092 | -169,320 |
| Sale Of Investment | 11,420 | 181,352 | 196,728 | 288,462 | 94,624 |
| Purchase Sale Intangibles | -1,707 | -4,404 | -5,174 | -3,248 | -4,762 |
| Other Investing Activity | -1,707 | -4,404 | -4,588 | -3,624 | -4,577 |
| Investing Cash Flow | $-21,995 | $-932 | $-97,157 | $32,635 | $-79,597 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Debt Repayment | -471 | -10,420 | -8,961 | -12,273 | -2,727 |
| Common Stock Issued | 9,345 | 1,023 | 71,247 | 995 | 101,551 |
| Other Financing Activity | -5,371 | 1,847 | -28 | -25,751 | 4,018 |
| Financing Cash Flow | $3,503 | $-7,550 | $62,258 | $-37,029 | $117,842 |
| Exchange Rate Effect | -656 | -416 | -7 | N/A | N/A |
| Beginning Cash Position | 55,633 | 42,332 | 27,687 | 52,203 | 34,376 |
| End Cash Position | 28,962 | 55,633 | 42,332 | 27,687 | 52,203 |
| Net Cash Flow | $-26,671 | $13,301 | $14,645 | $-24,516 | $17,827 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,523 | 22,199 | 49,551 | -20,122 | -20,418 |
| Capital Expenditure | -6,711 | -4,242 | -1,103 | -111 | -324 |
| Free Cash Flow | -14,234 | 17,957 | 48,448 | -20,233 | -20,742 |